Capecitabinechemicalstructure (Capecitabinechemicalstructure)
Capecitabine Tablet, Film Coated
Product Images NDC 72603-303
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 72603-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Capecitabinefigure1 (Capecitabinefigure1)
Capecitabinefigure2 (Capecitabinefigure2)
Capecitabinefigure3 (Capecitabinefigure3)
This is a medical text discussing the use of 5-FU + Leucovorin (Mayo Regimen) and Capecitabine 1250 mg/sqm twice daily for treatment. It also includes a table with estimated probabilities ranging from 0.0 to 1.0.*
Capecitabinefigure4 (Capecitabinefigure4)
This is a graph showing the estimated probability over time for different chemotherapy treatments: Docetaxel at 100 mg/sqm every 3 weeks, capecitabine at 1250 mg/sqm twice daily intermittently, and a combination of widocetaxel at 75 mg/sqm every 3 weeks. The x-axis represents time in days, while the y-axis represents the probability scale from 0.0 to 1.0.*
Capecitabinefigure5 (Capecitabinefigure5)
This text appears to be a table displaying estimated probabilities for different treatments involving Docetaxel and Capecitabine over time (Days). The table shows the dosage in milligrams per square meter for each treatment option. The probabilities seem to be categorized with values from 0.0 to 1.0. The information in this table could be useful for evaluating the effectiveness and potential outcomes of different drug regimens in cancer treatment.*
Capecitabinetablets500mg120s (Capecitabinetablets500mg120s)
This text is a description of Capecitabine tablets, a hazardous drug used as a cytotoxic agent. Each film-coated tablet contains 500 mg of the active ingredient. It provides the recommended dosage information and instructions for patients: to be swallowed whole with water within 30 minutes of a meal, without crushing or cutting. The tablets should be stored in tight containers at room temperature. The product is manufactured by Hetero Labs Limited in India for Northstar Rx LLC in Memphis, TN.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
